ADAR1 Capital Management »

Centessa Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $373k 23k 15.99
2024-06-30 $2.3M 253k 9.03
2024-03-31 $2.3M 207k 11.30

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Centessa Pharmaceuticals

Medicxi Ventures Management
General Atlantic
Perceptive Advisors
First Light Asset Management
T. Rowe Price Associates
Adage Capital Partners GP
Vida Ventures Advisors
T. Rowe Price Investment Management
Siren
EcoR1 Capital
FMR
TCG Crossover Management
Farallon Capital Management
Point72 Asset Management
Cormorant Asset Management

View all funds holding Centessa Pharmaceuticals